Inovirus-Encoded Peptides Induce Specific Toxicity in Pseudomonas aeruginosa

Juehua Weng, Yunxue Guo, Jiayu Gu, Ran Chen, Xiaoxue WangViruses 2025 · DOI

TL;DR

Researchers have identified a novel, 33-amino-acid polypeptide, PftP4, encoded by the Pf4 filamentous phage of Pseudomonas aeruginosa. This peptide selectively targets and kills P. aeruginosa by disrupting its cell membrane, offering a promising new avenue for combating this dangerous opportunistic pathogen, especially in the face of rising antibiotic resistance.

What Problem Does This Paper Address?

Pseudomonas aeruginosa is a formidable opportunistic pathogen responsible for numerous hospital-acquired infections, particularly in immunocompromised individuals and those with cystic fibrosis. Its ability to form resilient biofilms and its notorious resistance to multiple antibiotics make it a significant threat to public health, straining healthcare systems and leading to high mortality rates. While phage therapy is a promising alternative to antibiotics, the presence of filamentous prophages (Pf phages) within P. aeruginosa can actually hinder phage therapy by encoding genes that confer resistance or defense mechanisms. This paper tackles the challenge of finding novel, targeted ways to combat P. aeruginosa by investigating the potential of these prophage-encoded genes, specifically looking for those that might possess antimicrobial properties.

Methods

The study employed a multi-pronged approach:

  • Genomic Analysis: They identified a previously unannotated 102 bp gene (later named pftP4) co-transcribed with the zot gene (involved in phage release) in the Pf4 prophage.
  • Gene Cloning and Overexpression: The pftP4 gene was cloned into expression vectors (pHERD20T and pHGE) to overexpress the PftP4 polypeptide in P. aeruginosa and other bacterial strains.
  • Toxicity Assays: Bacterial viability assays (using LIVE/DEAD staining) and plate-based toxicity assays were performed to assess the effect of PftP4 overexpression on various bacterial strains.
  • Subcellular Localization: A green fluorescent protein (GFP) tag was fused to PftP4 to visualize its location within P. aeruginosa cells using fluorescence microscopy.
  • Membrane Integrity Assay: The SYTOX™ green stain, which only enters cells with compromised membranes, was used to evaluate the impact of PftP4 on cell membrane permeability.
  • Homologue Search: Bioinformatic tools were used to search for PftP4 homologues in other Pf phages and in viral databases.
  • Gene Knockout: Deletion mutants of pftP4 and its related gene pftO were created to understand their specific roles in phage production and toxicity.
  • Quantitative PCR (qPCR): Used to assess gene expression levels and phage excision/replication frequencies.

Datasets

  • Bacterial Strains: A collection of Pseudomonas aeruginosa strains (including the laboratory strain MPAO1 and several clinical isolates), Escherichia coli (MG1655), and Providencia stuartii were used. Halomonas meridiana was also included.
  • Plasmids: Various expression plasmids (pHERD20T-based and pHGE-based) were used for gene cloning and overexpression.
  • Viral Databases: The IMG/VR database was searched for PftP4 homologues.

No new benchmarks were introduced; the study focused on characterizing the function of a newly identified gene.

Key Insights and Ideas

  • A Hidden Toxin: The Pf4 prophage, previously known for its role in phage biology, harbors a small, uncharacterized gene (pftP4) that encodes a potent toxic peptide. This highlights that even seemingly simple viral genomes can contain sophisticated antimicrobial mechanisms.
  • Targeted Cell Membrane Disruption: PftP4's toxicity isn't a general cellular poison; it specifically targets the cell membrane of P. aeruginosa, leading to increased permeability and cell death. This specificity is crucial for developing targeted therapies with minimal off-target effects.
  • Evolutionary Arms Race: The specific toxicity of PftP4 towards P. aeruginosa is likely a result of long-term co-evolution between the phage and its host, suggesting a sophisticated interplay of defense and counter-defense mechanisms.
  • Beyond the Full-Length Peptide: While the full 33-amino-acid PftP4 is toxic, shorter truncated versions did not exhibit significant toxicity, suggesting the full sequence is required for its potent effect.
  • Widespread Potential: The discovery of PftP4 homologues in multiple Pf phages indicates that this toxic peptide mechanism is not unique to Pf4 and may be a common strategy employed by these phages against P. aeruginosa.

Key Results

  • PftP4 is Toxic: Overexpression of PftP4 in P. aeruginosa led to significant cell death, as demonstrated by viability assays.
  • Membrane Localization and Permeability: PftP4 was localized to the cell membrane, and its presence increased membrane permeability, as evidenced by SYTOX™ green staining.
  • Specificity: PftP4 exhibited toxicity towards P. aeruginosa (both laboratory and clinical strains) but not towards E. coli or P. stuartii, even when expressed at significant levels.
  • Phage Secretion vs. Toxicity: The gene pftO (PA0726) was confirmed to be essential for phage secretion, while pftP4 (PA0726.1) was responsible for the observed toxicity. Deleting pftO blocked phage release, while deleting pftP4 did not significantly impact phage production but reduced toxicity.
  • Homologue Prevalence: A search revealed 427 PftP4 homologues in viral genomes, predominantly from the Inoviridae family, with a high sequence identity and a tendency to infect Pseudomonas.

Limitations and Future Work

  • Delivery Mechanism: While PftP4 demonstrates potent toxicity when overexpressed intracellularly, its effectiveness when administered externally is limited, likely due to poor cell penetration. The authors suggest exploring suitable drug delivery vehicles to enhance its efficacy.
  • In Vivo Efficacy: The study focused on in vitro experiments. Future work should investigate the efficacy and safety of PftP4 in animal models and ultimately in human clinical trials.
  • Mechanism Details: While membrane disruption is identified as the mechanism, further research could elucidate the precise molecular interactions and pore formation induced by PftP4.
  • Broader Applications: The study suggests exploring PftP4 and its homologues for treating P. aeruginosa infections in hospital environments and investigating their potential in other bacterial hosts where filamentous phages are prevalent.

Summary updated

Abstract

<i>Pseudomonas aeruginosa</i> is a common opportunistic pathogen associated with nosocomial infections. The primary treatment for infections typically involves antibiotics, which can lead to the emergence of multidrug-resistant strains. Therefore, there is a pressing need for safe and effective alternative methods. Phage therapy stands out as a promising approach. However, filamentous prophages (Pfs) commonly found in <i>P. aeruginosa</i> encode genes with phage defense activity, thereby reducing the efficacy of phage therapy. Through a genomic analysis of the Pf4 prophage, we identified a 102 bp gene co-transcribed with the upstream gene responsible for phage release (<i>zot</i> gene), giving rise to a 33-amino-acid polypeptide that we have named Pf4-encoded toxic polypeptide (PftP4). The overexpression of PftP4 demonstrated cellular toxicity in <i>P. aeruginosa</i>, with subcellular localization indicating its presence in the cell membrane and a subsequent increase in membrane permeability. Notably, PftP4 homologues are found in multiple Pf phages and exhibit specificity in their toxicity towards <i>P. aeruginosa</i> among the tested bacterial strains. Our study reveals that the novel Pf-encoded polypeptide PftP4 has the potential to selectively target and eradicate <i>P. aeruginosa</i>, offering valuable insights for combating <i>P. aeruginosa</i> infections.
BibTeX
@inproceedings{weng2025inovirus,
  author = {Juehua Weng and Yunxue Guo and Jiayu Gu and Ran Chen and Xiaoxue Wang},
  title = {{Inovirus-Encoded Peptides Induce Specific Toxicity in Pseudomonas aeruginosa}},
  booktitle = {Viruses},
  year = {2025},
  doi = {10.3390/v17010112},
}
Figure